Real-World Observational Study on Patient-Reported Outcomes in the Treatment of Insomnia with Daridorexant in Canada

NCT06311864 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Daridorexant 50 mg

Sponsor

PeriPharm

Collaborators

[object Object]